
Global law firm Norton Rose Fulbright announced that Carsten Reichel, who previously spent more than a decade as a federal prosecutor of criminal antitrust cartels at the United States Department of Justice (DOJ) Antitrust Division, has joined its Washington, DC office as a partner.
As a prosecutor, Reichel spearheaded some of the Antitrust Division’s most significant international criminal cartel matters, including in the shipping, pharmaceuticals, auto parts, air cargo and foreign currency exchange industries, as well as numerous domestic matters involving procurement fraud, corruption and related conspiracies. Reichel also negotiated and oversaw the first-ever antitrust compliance monitor imposed under an Antitrust Division corporate plea agreement and led the efforts to expand the
DOJ’s Procurement Collusion Strike Force initiative to detect and deter criminal cartel activity by federal and state contractors.
In addition to his prosecutorial work, Reichel worked on key policy and interagency initiatives while at DOJ, including advising on the implementation of the Criminal Antitrust Anti-Retaliation Act, overseeing competition compliance in multi-agency efforts to implement the Defense Production Act responses to the COVID-19 pandemic and also advising and training numerous foreign competition enforcers on cartel enforcement practices and policies as an international counsel.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Intel Challenges €376 Million EU Fine in Ongoing Antitrust Dispute
May 19, 2025 by
CPI
Red Bull Challenges EU Commission Over Lengthy Antitrust Inspection
May 19, 2025 by
CPI
Live Nation Under Criminal Antitrust Investigation Over Pandemic-Era Refund Policies
May 19, 2025 by
CPI
BCLP Strengthens Healthcare and Antitrust Litigation Practice
May 19, 2025 by
CPI
Italy Fines AI Chatbot Maker Replika €5 Million Over Privacy Violations
May 19, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas